Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7 - Identification of a critical aromatic amino acid residue at position 33

被引:39
|
作者
Barre, Lydia
Fournel-Gigleux, Sylvie
Finel, Moshe
Netter, Patrick
Magdalou, Jacques
Ouzzine, Mohamed
机构
[1] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France
[2] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
关键词
site-directed mutagenesis; substrate specificity; UDP-glucuronosyltransferase; UGT2B4; UGT2B7;
D O I
10.1111/j.1742-4658.2007.05670.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human UDP-glucuronosyltransferase (UGT) isoforms UGT2B4 and UGT2B7 play a major role in the detoxification of bile acids, steroids and phenols. These two isoforms present distinct but overlapping substrate specificity, sharing common substrates such as the bile acid hyodeoxycholic acid (HDCA) and catechol-estrogens. Here, we show that in UGT2B4, substitution of phenylalanine 33 by leucine suppressed the activity towards HDCA, and impaired the glucuronidation of several substrates, including 4-hydroxyestrone and 17-epiestriol. On the other hand, the substrate specificity of the mutant UGT2B4F33Y, in which phenylalanine was replaced by tyrosine, as found at position 33 of UGT2B7, was similar to wild-type UGT2B4. In the case of UGT2B7, replacement of tyrosine 33 by leucine strongly reduced the activity towards all the tested substrates, with the exception of 17-epiestriol. In contrast, mutation of tyrosine 33 by phenylalanine exhibited similar or even somewhat higher activities than wild-type UGT2B7. Hence, the results strongly indicated that the presence of an aromatic residue at position 33 is important for the activity and substrate specificity of both UGT2B4 and UGT2B7.
引用
收藏
页码:1256 / 1264
页数:9
相关论文
共 29 条
  • [21] Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate
    Ji, Jin-Zi
    Huang, Bei-Bei
    Gu, Tong-Tong
    Tai, Ting
    Zhou, Huan
    Jia, Yu-Meng
    Mi, Qiong-Yu
    Zhang, Meng-Ran
    Xie, Hong-Guang
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (02) : 88 - 98
  • [22] UGT2B10 is the Major UDP-Glucuronosyltransferase 2B Isoform Involved in the Metabolism of Lamotrigine and is Implicated in the Drug-Drug Interaction with Valproic Acid
    Tang, Lloyd Wei Tat
    Lapham, Kimberly
    Goosen, Theunis C.
    AAPS JOURNAL, 2024, 26 (06):
  • [23] Asp85Tyr polymorphism in the UDP-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer
    Park, J
    Chen, L
    Shade, K
    Lazarus, P
    Seigne, J
    Patterson, S
    Helal, M
    Pow-Sang, J
    JOURNAL OF UROLOGY, 2004, 171 (06) : 2484 - 2488
  • [24] Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes
    Konopnicki, Camille M.
    Dickmann, Leslie J.
    Tracy, Jeffrey M.
    Tukey, Robert H.
    Wienkers, Larry C.
    Foti, Robert S.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2013, 535 (02) : 143 - 149
  • [25] Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents
    Abdullah, Nurul Huda
    Ismail, Sabariah
    MOLECULES, 2018, 23 (10):
  • [26] Identification and validation of the microRNA response elements in the 3′-untranslated region of the UDP glucuronosyltransferase (UGT)2B7 and 2B15 genes by a functional genomics approach
    Papageorgiou, Ioannis
    Court, Michael H.
    BIOCHEMICAL PHARMACOLOGY, 2017, 146 : 199 - 213
  • [27] Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6*2, 1A7*12, 1A8*3, 1A9*3, 2B7*2, and 2B15*2) in a Saudi population
    Alkharfy, Khalid M.
    Jan, Basit L.
    Afzal, Sibtain
    Al-Jenoobi, Fahad I.
    Al-Mohizea, Abdullah M.
    Al-Muhsen, Saleh
    Halwani, Rabih
    Parvez, Mohammad K.
    Al-Dosari, Mohammed S.
    SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (02) : 224 - 230
  • [28] Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT
    Miyauchi, Yuu
    Kurita, Ayumi
    Yamashita, Ryohei
    Takamatsu, Tomoyuki
    Ikushiro, Shinichi
    Mackenzie, Peter, I
    Tanaka, Yoshitaka
    Ishii, Yuji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 525 (02) : 348 - 353
  • [29] Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer
    Menard, Vincent
    Levesque, Eric
    Chen, Sylvia
    Eap, Olivier
    Joy, Melanie S.
    Ekstrom, Lena
    Rane, Anders
    Guillemette, Chantal
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (12) : 684 - 696